Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06224673Phase 2Recruiting
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
HER2 Low Breast CarcinomaHormone Receptor Positive Breast CarcinomaHormone-receptor-positive Breast Cancer+1 more
PrincipalinvestigatorStart date: 2026-06-05
NCT03971409Phase 2Active Not Recruiting
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
Invasive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer+6 more
PrincipalinvestigatorStart date: 2019-07-08
NCT07659652Not Yet Recruiting
Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
Brain Metastases From Breast CancerBreast Cancer, MetastaticBreast Cancer, Metastatic Breast Cancer+2 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michelle Melisko, MD

University of California, San Francisco

Similar
5 trials

Shared therapeutic areas:

Brain Metastases From Breast CancerBreast Cancer MetastaticBreast Cancer, Metastatic Breast Cancer+2 more

Worked with same sponsors:

University of California, San Francisco
Collaborated on 1 trial
Similarity Score54%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Stage III Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+2 more
Similarity Score8%

Joanne Mortimer

City of Hope Medical Center

Related
8 trials

Shared therapeutic areas:

Stage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+2 more
Similarity Score8%

Agustin Garcia, MD

University of Southern California

Related
8 trials

Shared therapeutic areas:

Stage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+2 more
Similarity Score8%

Hannah Linden

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
7 trials

Shared therapeutic areas:

Stage IIIA Breast CancerStage IV Breast CancerStage IIIB Breast Cancer+1 more
Similarity Score7%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Stage IIIA Breast CancerStage IIIB Breast CancerStage IV Breast Cancer+1 more

Worked with same sponsors:

Breast Cancer Research FoundationPfizer
Similarity Score7%

Shari Goldfarb, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Hormone Receptor Positive Breast CarcinomaHormone-receptor-positive Breast CancerStage III Breast Cancer
Similarity Score5%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Stage IV Breast CancerTriple-negative Breast Carcinoma
Similarity Score3%

Shannon N Westin

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Recurrent Breast CarcinomaTriple-negative Breast Carcinoma
Similarity Score3%

Jennifer Ligibel, MD

Dana-Farber Cancer Institute

Related
11 trials

Shared therapeutic areas:

Invasive Breast CarcinomaStage III Breast Cancer

Worked with same sponsors:

Breast Cancer Research Foundation
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06224673Phase 2PrincipalInvestigator

ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

HER2 Low Breast CarcinomaHormone Receptor Positive Breast CarcinomaHormone-receptor-positive Breast Cancer+1 more
Recruiting
NCT03971409Phase 2PrincipalInvestigator

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Invasive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer+6 more
Active Not Recruiting
NCT07659652PrincipalInvestigator

Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease

Brain Metastases From Breast CancerBreast Cancer, MetastaticBreast Cancer, Metastatic Breast Cancer+2 more
Not Yet Recruiting

All 3 trials loaded